Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.42% | 4.31% | 1.31% | 8.35% | 9.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.65% | -41.04% | -40.84% | -15.19% | 12.62% |
| Operating Income | -32.65% | 41.04% | 40.84% | 15.19% | -12.62% |
| Income Before Tax | -34.34% | 41.41% | 40.94% | 11.70% | -27.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.34% | 41.41% | 40.94% | 11.70% | -27.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.34% | 41.41% | 40.94% | 11.70% | -27.94% |
| EBIT | -32.65% | 41.04% | 40.84% | 15.19% | -12.62% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 18.57% | 42.07% | 41.53% | 12.58% | -26.81% |
| Normalized Basic EPS | 18.55% | 42.06% | 41.53% | 12.59% | -26.79% |
| EPS Diluted | 18.57% | 42.07% | 41.53% | 12.58% | -26.81% |
| Normalized Diluted EPS | 18.55% | 42.06% | 41.53% | 12.59% | -26.79% |
| Average Basic Shares Outstanding | 64.98% | 1.13% | 1.01% | 1.00% | 0.88% |
| Average Diluted Shares Outstanding | 64.98% | 1.13% | 1.01% | 1.00% | 0.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |